Common Equity: The sum of all common equity items.
Clearmind Medicine Inc. (CMND) had Common Equity of $12.95M for the most recently reported fiscal quarter, ending 2026-07-31.
| Income Statement Financials | |
-- |
|
$-0.91M |
|
-- |
|
-- |
|
$2.18M |
|
$-2.18M |
|
$1.28M |
|
$-0.90M |
|
$-0.90M |
|
$-0.91M |
|
$-0.91M |
|
$-0.91M |
|
$-0.91M |
|
$-2.18M |
|
$-2.18M |
|
0.20M |
|
0.20M |
|
$-4.56 |
|
$-4.56 |
|
| Balance Sheet Financials | |
$16.63M |
|
-- |
|
$0.28M |
|
$16.91M |
|
$3.86M |
|
$0.10M |
|
$0.10M |
|
$3.96M |
|
|
Common Equity |
$12.95M |
$12.86M |
|
$12.95M |
|
0.27M |
|
| Cash Flow Statement Financials | |
$-5.78M |
|
$-1.43M |
|
$15.33M |
|
$3.92M |
|
$12.04M |
|
$8.11M |
|
$1.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.31 |
|
-- |
|
-- |
|
0.01 |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.01% |
|
-7.05% |
|
-5.36% |
|
-6.95% |
|
$48.30 |
|
$-29.25 |
|
$-29.25 |
|